Two steps forward, one step back; paradigmatic changes in psychiatry

Journal of Neural Transmission

Volumn 108, Issue 6, 2001, Pages 617-627

  Verhoeven, W M A ^a   Tuinier, S ^b  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Functional psychopathology; Gene expression; Mental retardation; Personality disorders

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; FEMALE; GENE EXPRESSION; GENETIC DISORDER; HABIT; HUMAN; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROSCIENCE; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; CHILD; FEMALE; HUMANS; MENTAL RETARDATION; PERSONALITY DISORDERS; PSYCHIATRY;

EID: 0034924014     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020170039     Document Type: Article

References (77)

1. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
2. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
3. Die rolle des serotonins in der verhaltensmodulation
4. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review
5. X-linked borderline mental retardation with prominent behavioural disturbance: Phenotype, genetic localization, and evidence for disturbed monoamine metabolism
6. A systematic method for clinical description and classification of personality variants. A proposal
7. A psychobiological model of temperament and character
8. Frontal-subcortical circuits and human behavior
9. The clinician-scientist in neuropsychiatry: A position statement from the committee on research of the American Neuropsychiatric Association
10. Comprehensive review of the psychiatric uses of valproate
11. Brain corticosteroid receptor balance and homeostatic control
12. Brain-corticosteroid hormone dialogue: Slow and persistent
13. Stress and cognition: Are corticosteroids good or bad guys?
14. Beyond specificity: Effects of serotonin and serotonergic treatments on psychobiological dysfunction
15. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers
16. Neural systems, emotions and personality
17. Adrenocortical responses to the strange situation in infants with disorganized/disoriented attachment relationships
18. The rationale for corticotropin-release hormone receptor (CRH-R) antagonists to treat depression and anxiety
19. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment
20. A new intellectual framework for psychiatry
21. Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited
22. Selective alteration of personality and social behavior by serotonergic intervention
23. The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Current concepts and relations to impulsive behavior in humans
24. Stability and changes in personality disorder features
25. Does haloperidol block methylphenidate? Motivation or attention?
26. Apathy: A neuropsychiatric syndrome
27. Apathy: A treatable syndrome
28. Mechanisms of action of valproate in affective disorders
29. Low salivary cortisol and persistent aggression in boys referred for disruptive behavior
30. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage
31. Relationships between parenting and adolescent adjustment over time: Genetic and environmental contriburions
32. The etiology of borderline personality disorder: A biopsychosocial approach
33. The genetic basis of complex human behaviours
34. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
35. Neurology and psychiatry. Closing the great divide
36. Autonomic nervous system factors underlying disinhibited, antisocial, and violent behavior
37. Relationships between central and autonomic measures of arousal at age 15 years and criminality at age 24 years
38. Changes in DSM-III-R Axis II diagnoses following treatment obsessive-compulsive disorder
39. Synaptic effects of antidepressants
40. Changes in pathological narcissism
41. Neonatal maternally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine
42. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness
43. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives
44. Behavior and the basal ganglia
45. 1a receptor function in healthy human males: Hypothermic, hormonal, and behavioural responses to ipsapirone
46. Research diagnostic criteria
47. Differential diagnosis of personality disorders by the seven-factor model of temperament and character
48. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans
49. Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis
50. Motivational deficit syndrome; a specific entity?
51. Neurobiology of aggression and impulsity
52. Cerebrospinal fluid 5-hydroxyindolacetic acid and agression, a critical reappraisal of the clinical data
53. Neuropsychiatric and biochemical characteristics of X-linked MAO-A deficiency syndrome. A single case intervention study
54. Serotonin and disruptive behavior. A critical evaluation of the clinical data
55. Salivary cortisol and cardiovalcular activity during stress in oppositional-defiant disorder boys and normal controls
56. The role of biological psychiatry in psychiatry
57. Two-tier diagnosis in psychiatry
58. Barking up the wrong tree. Towards a more effective system of psychiatric diagnosing
59. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)
60. Over the mainstream: Diagnostic requirements for biological psychiatric research
61. Neubewertung des syndroms. Skizze einer funktionellen pathologie
62. Dopamine metabolism in depression, psychoses and Parkinson's disease: The problem of the specificity of biological variables in behavioral disorders
63. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology
64. The effect of buspirone on challenging behaviour in mentally retarded patients: An open prospective multiple-case study
65. Serotonin 1a agonist buspirone in disruptive behaviour
66. Valproic acid in unstable mood disorder
67. Dysperceptions and serotonergic parameters in borderline personality disorder; effects of treatment with risperidone
68. Stress and self-injurious behaviour; hormonal and serotonergic parameters in mentally retarded subjects
69. Prader-Willi Syndrome: A concise review of the genetic, pathophysiological and neuropsychiatric characteristics
70. Prader-Willi psychiatric syndrome and velo-cardio-facial psychiatric syndrome
71. Dopaminergic mechanisms in depression and mania
72. Diagnosing personality disorders. A review of issues and research methods
73. Axis I diagnostic comorbidity and borderline personality disorder